Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years

NCT01376427 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia Ph Positive

Interventions

DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Vincristine

Sponsor

PETHEMA Foundation